Security key
09061G101
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,632,743
- Total 13F shares
- 179,051,547
- Share change
- -3,393,461
- Total reported value
- $17,400,388,762
- Put/Call ratio
- 52%
- Price per share
- $97.24
- Number of holders
- 544
- Value change
- -$352,972,540
- Number of buys
- 260
- Number of sells
- 259
Report period
Q1 2023
Institutions
544
Top holders
10
BMRN full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
BIOMARIN PHARMACEUTICAL INC SEC filings
BIOMARIN PHARMACEUTICAL INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09061G101
Recent filing periods:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
9.1%
|
17,580,859
|
$1,819,443,098 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
9%
|
17,365,080
|
$1,797,112,129 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.5%
|
14,540,191
|
$1,504,764,369 | — | 31 Dec 2022 | |
| DODGE & COX |
13F
|
Company |
7.5%
|
14,383,663
|
$1,488,565,284 | — | 31 Dec 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
4%
|
7,620,494
|
$788,644,924 | — | 31 Dec 2022 | |
| Capital Research Global Investors |
13F
|
Company |
2.9%
|
5,651,001
|
$584,800,024 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.8%
|
5,388,844
|
$557,691,466 | — | 31 Dec 2022 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
2.7%
|
5,273,620
|
$545,766,934 | — | 31 Dec 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
2.4%
|
4,648,628
|
$481,102,000 | — | 31 Dec 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2%
|
3,888,444
|
$402,402,533 | — | 31 Dec 2022 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.8%
|
3,555,555
|
$367,964,387 | — | 31 Dec 2022 | |
| NORGES BANK |
13F
|
Company |
1.4%
|
2,754,017
|
$285,013,219 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
2,584,104
|
$267,112,000 | — | 31 Dec 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
2,560,643
|
$265,001,000 | — | 31 Dec 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.2%
|
2,388,766
|
$247,213,394 | — | 31 Dec 2022 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
1.2%
|
2,338,529
|
$242,014,366 | — | 31 Dec 2022 | |
| BARCLAYS PLC |
13F
|
Company |
1%
|
1,982,489
|
$205,167,787 | — | 31 Dec 2022 | |
| Palo Alto Investors LP |
13F
|
Company |
0.98%
|
1,885,811
|
$195,162,580 | — | 31 Dec 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.95%
|
1,835,061
|
$189,910,463 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.88%
|
1,703,799
|
$176,326,158 | — | 31 Dec 2022 | |
| Amundi |
13F
|
Individual |
0.87%
|
1,673,693
|
$186,030,977 | — | 31 Dec 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.84%
|
1,615,210
|
$167,158,083 | — | 31 Dec 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.77%
|
1,478,521
|
$153,012,000 | — | 31 Dec 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.73%
|
1,409,124
|
$145,830,243 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.68%
|
1,305,190
|
$135,074,113 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.64%
|
1,241,980
|
$128,532,511 | — | 31 Dec 2022 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.64%
|
1,233,289
|
$127,633,079 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.61%
|
1,171,051
|
$121,192,109 | — | 31 Dec 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0.61%
|
1,168,215
|
$120,898,481 | — | 31 Dec 2022 | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ |
13F
|
Company |
0.59%
|
1,146,055
|
$118,605,000 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.59%
|
1,145,414
|
$118,538,894 | — | 31 Dec 2022 | |
| 1832 Asset Management L.P. |
13F
|
Company |
0.58%
|
1,125,806
|
$116,509,662 | — | 31 Dec 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.57%
|
1,102,289
|
$114,075,889 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.57%
|
1,095,356
|
$113,358,557 | — | 31 Dec 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.53%
|
1,013,561
|
$104,893,427 | — | 31 Dec 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.48%
|
927,836
|
$96,021,000 | — | 31 Dec 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.48%
|
920,000
|
$95,210,800 | — | 31 Dec 2022 | |
| Manning & Napier Group, LLC |
13F
|
Company |
0.45%
|
874,566
|
$90,508,835 | — | 31 Dec 2022 | |
| Gestion Carmignac |
13F
|
Individual |
0.45%
|
868,612
|
$89,892,656 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.41%
|
785,450
|
$81,286,000 | — | 31 Dec 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.4%
|
766,372
|
$79,311,838 | — | 31 Dec 2022 | |
| Swiss National Bank |
13F
|
Company |
0.39%
|
753,800
|
$78,010,762 | — | 31 Dec 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.38%
|
736,914
|
$76,263,230 | — | 31 Dec 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.37%
|
716,700
|
$74,171,283 | — | 31 Dec 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.37%
|
704,748
|
$72,934,000 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.35%
|
667,284
|
$69,057,221 | — | 31 Dec 2022 | |
| Man Group plc |
13F
|
Company |
0.34%
|
663,969
|
$68,714,152 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.33%
|
630,271
|
$65,227,000 | — | 31 Dec 2022 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.32%
|
612,349
|
$63,371,998 | — | 31 Dec 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.31%
|
600,272
|
$62,122,148 | — | 31 Dec 2022 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q1 2023
As of 31 Mar 2023,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
544 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
179,051,547 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., Dodge & Cox, Capital Research Global Investors, STATE STREET CORP, AMERIPRISE FINANCIAL INC, Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, and BANK OF AMERICA CORP /DE/.
This page lists
546
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
570
Q1 2023 holders
544
Holder diff
-26
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.